Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank84
5Y CAGR-18.4%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
-18.4%/yr
Long-term compound
Percentile
P84
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 14.83% |
| Q3 2025 | -8.42% |
| Q2 2025 | -5.13% |
| Q1 2025 | 50.66% |
| Q4 2024 | -2.52% |
| Q3 2024 | -5.34% |
| Q2 2024 | 43.42% |
| Q1 2024 | -14.50% |
| Q4 2023 | -9.19% |
| Q3 2023 | -9.20% |
| Q2 2023 | -14.38% |
| Q1 2023 | 7.24% |
| Q4 2022 | -9.48% |
| Q3 2022 | -9.37% |
| Q2 2022 | -10.83% |
| Q1 2022 | 8.39% |
| Q4 2021 | -8.50% |
| Q3 2021 | -7.01% |
| Q2 2021 | -6.55% |
| Q1 2021 | -8.86% |
| Q4 2020 | 40.99% |
| Q3 2020 | -5.96% |
| Q2 2020 | -5.56% |
| Q1 2020 | -26.44% |
| Q4 2019 | 23.97% |
| Q3 2019 | -6.86% |
| Q2 2019 | 133.16% |
| Q1 2019 | -26.38% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |